NCT04743661 2026-02-05131I-Omburtamab, in Recurrent Medulloblastoma and EpendymomaPediatric Brain Tumor ConsortiumPhase 2 Active not recruiting62 enrolled
NCT07346157 2026-01-16PNOC044University of California, San FranciscoPhase 1/2 Not yet recruiting69 enrolled
NCT05017610 2022-12-02Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or GliosarcomaEmory UniversityPhase EARLY_PHASE1 Withdrawn